Eton Pharmaceuticals, Inc. 8-K

What Happened Eton Pharmaceuticals, Inc. (ETON) announced its financial results for the quarter ended March 31, 2026 via a press release dated May 14, 2026. The company furnished the press release as Exhibit 99.1 to a Form 8-K (filed May 14, 2026) under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: May 14, 2026 (Form 8-K).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026).
• Press release announcing the results is attached as Exhibit 99.1 to the Form 8-K.
• Items reported on the Form 8-K: Item 2.02 (Results of Operations and Financial Condition) and related exhibits in Item 9.01.

Why It Matters Quarterly financial results provide updated information on Eton’s earnings, revenue trends, and cash/operating performance, which can influence the stock and investor decisions. Investors should read the attached press release (Exhibit 99.1) for the specific revenue, expense, net income/loss, and any management commentary or outlook included in the announcement.